Autistic spectrum conditions in adults


 

 

Summary

[Anticipated publication date TBC]

    The final scope is available for download here.

    The scope of the guideline covers:

    • Signs and symptoms that should prompt professionals working with adults and/or their carers to consider the possibility of an autism spectrum condition in adults. These will include signs and symptoms that should trigger referral for specialist assessment.
    • Validity, specificity and reliability of the components of diagnostic assessment after referral, including: structure for assessment, including strengths and skills of the individual; diagnostic thresholds; assessment tools, including imaging, genetic and biomedical techniques; risk assessment; the impact of coexisting developmental, mental and physical conditions on the assessment.
    • Psychosocial interventions, includingbut not limited to: applied behavioural analysis; cognitive behavioural therapies; social groups; befriending schemes; mentoring; supported employment programmes.
    • Pharmacological interventions, including but not limited to: anticonvulsants, antidepressants, and antipsychotics for the treatment of symptoms that may arise from coexisting conditions.
    • Physical interventions, such as diet.
    • Information and day-to-day support (such as a telephone helpline or advocates) for adults with a suspected autism spectrum condition, and their families and carers, during the process of referral, assessment and diagnosis.
    • The organisation and delivery of care, and care pathways for the effective components of treatment and management (including transition planning), based on an ethos of multi-professional working.

    This scope of the guideline does not cover:

    • Coexisting conditions if an autism spectrum condition is not the primary diagnosis.

Consultation documents

[Consultation on draft guideline: 11 October 2010 - 8 November 2010; Anticipated publication date 25 May 2011]

    Registered stakeholders for the Common mental health disorders: identification and care pathways guideline are invited to submit comments on the scope and may suggest clinical questions that could be answered in the guideline. Individuals and organisations not registered as stakeholders are not able to comment, we recommend that you register as a stakeholder or you contact the registered stakeholder organisation that most closely represents your interests and pass your comments to them [please refer to the NICE website for more information on how to submit comments on the provisional recommendations set out in the above documents].